Applied BioCode: Chris Bernard
Mar 24, 2022
Chris Bernard has been appointed as CEO of Applied BioCode. Most recently, he was CEO of cancer diagnostics firm Oncogenesis, and before that, CEO of infectious disease diagnostics firm Curetis. He also held various commercial executive positions at Epic Sciences, Metabolon, Abaxis, and Cytyc.